Coming Up
Laer today we will look at the background paper being presented to legislators at Monday's hearing into IP and stem cell research. The paper says, among other things, that the IP options include open source or nonexclusive licensing and sharing of basic research findings and tools.
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.